Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-03-09Clinical Trial Update: NOLAN: Naproxen or Loratadine and Neulasta [Phase 2]
Phase 2 trial update for naproxen or loratadine with Neulasta in bone pain associated with stage I-III breast cancer; results posted in 2016…
-
CLINICAL_TRIALS trial_result · 2016-03-08Clinical Trial Update: Physical Activity, Fatigue, Sleep, and Inflammation [NA]
Completed clinical trial evaluating how physical activity relates to fatigue, sleep, and inflammation in breast cancer patients.
-
CLINICAL_TRIALS trial_result · 2016-03-07Clinical Trial Update: Observational Study to Evaluate Mechanisms of Aromatase Inhibitor Associated Musculoskeletal Symptoms
This completed observational study examined potential mechanisms underlying musculoskeletal symptoms associated with aromatase inhibitor the…
-
CLINICAL_TRIALS trial_result · 2016-03-03Clinical Trial Update: PTC299 and Hormonal Agent for Treatment of Metastatic Breast Cancer [Phase 1]
A Phase 1 clinical trial evaluating PTC-299 in combination with a hormonal agent for metastatic breast cancer has completed, focusing on saf…
-
CLINICAL_TRIALS trial_result · 2016-03-03Clinical Trial Update: Adjuvant Hypofractionated Intensity-Modulated Radiation Therapy With Incorporated Boost in Treating Patients With Early-Stage Breast Cancer [Phase 2]
A Phase 2 trial evaluating adjuvant hypofractionated intensity-modulated radiation therapy with an incorporated boost for early-stage breast…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2016-03-02FDA Approved: FASLODEX — Supplemental Application (AstraZeneca Pharmaceuticals LP)
The FDA approved a supplemental application for FASLODEX (fulvestrant) from AstraZeneca Pharmaceuticals LP. This action indicates regulatory…
-
FDA approval · 2016-03-01FDA Approved: FASLODEX — Supplemental Application (AstraZeneca Pharmaceuticals LP)
FDA approved Faslodex (fulvestrant) via a supplemental application from AstraZeneca Pharmaceuticals LP. The action represents a supplemental…
-
CLINICAL_TRIALS trial_result · 2016-03-01Clinical Trial Update: Efficacy and Optimal Dose Selection of Intranasal Dexmedetomidine During Breast Lumpectomy Under Local Anaesthesia [Phase 2]
Phase 2 trial update evaluating the efficacy and optimal dose of intranasal dexmedetomidine during breast lumpectomy under local anesthesia.
-
FDA approval · 2016-02-29FDA Approved: VABRINTY — Supplemental Application (URONOVA PHARMACEUTICALS, INC.)
FDA approved a supplemental application for VABRINTY (leuprolide acetate) submitted by URONOVA Pharmaceuticals.
-
CLINICAL_TRIALS research · 2016-02-29Clinical Trial Update: Study of Biomarkers in Tissue Samples From Patients With Breast Cancer
ClinicalTrials.gov update describes a biomarker study using tissue samples from patients with breast cancer; no results or status details pr…
-
CLINICAL_TRIALS trial_result · 2016-02-26Clinical Trial Update: Ketogenic Or LOGI Diet In a Breast Cancer Rehabilitation Intervention (KOLIBRI) [NA]
Completed results from the KOLIBRI trial evaluating a ketogenic/LOGI diet as a rehabilitation intervention for breast cancer patients to imp…
-
CLINICAL_TRIALS trial_result · 2016-02-26Clinical Trial Update: An Investigation of the Effect of the Promoter Polymorphism in the Glucuronosyltransferase 2B7 in Patients on Breast Cancer Treatment
A clinical trial examining the effect of a UGT2B7 promoter polymorphism on breast cancer treatment was terminated.
-
CLINICAL_TRIALS trial_result · 2016-02-25Clinical Trial Update: Administration During Chemotherapy to Reduce Ovarian Failure Following Chemotherapy in Early Stage, Hormone-Receptor Negative Breast Cancer [Phase 3]
Phase 3 trial evaluating whether administering a gonadotropin-releasing hormone agonist during chemotherapy reduces ovarian failure in women…
-
CLINICAL_TRIALS trial_result · 2016-02-25Clinical Trial Update: Prospective & Retrospective Data Collection of Breast Cancer Cases From 2000 to Present [EARLY_Phase 1]
This clinical trial update describes prospective and retrospective data collection of breast cancer cases from 2000 to the present in an EAR…
-
CLINICAL_TRIALS trial_result · 2016-02-25Clinical Trial Update: HepaSphere Interventional Therapy Using Digital Subtraction Angiography（DSA）for Breast Cancer [Phase 1, Phase 2]
This document reports the completion of a Phase 1/2 trial evaluating HepaSphere Interventional Therapy using Digital Subtraction Angiography…
-
CLINICAL_TRIALS research · 2016-02-25Clinical Trial Update: Changes in Biomarkers of Cancer in Women With Breast Cancer and Without Evidence of Disease Who Were Given PhytoMed™ [NA]
Clinical Trial Update reporting changes in cancer-related biomarkers in women with breast cancer who received PhytoMed and had no evidence o…
-
CLINICAL_TRIALS trial_result · 2016-02-24Clinical Trial Update: Trial of Mesna to Prevent Doxorubicin-induced Plasma Protein Oxidation and Tumor Necrosis Factor Alpha (TNF-α) Release [Phase 2]
Phase 2 trial evaluating mesna to prevent doxorubicin-induced plasma protein oxidation and TNF-α release in patients with breast cancer or n…
-
CLINICAL_TRIALS trial_result · 2016-02-24Clinical Trial Update: An Observational Study of Patients With HER2-Positive Metastatic or Locally Advanced Breast Cancer Treated With Herceptin (Trastuzumab) in 1st Line and Without Progression For 3 Years
An observational study of HER2-positive metastatic or locally advanced breast cancer patients treated with trastuzumab (Herceptin) as first-…
-
CLINICAL_TRIALS research · 2016-02-24Clinical Trial Update: Novel Surrogate Markers as Predictors of Radiation Toxicity in Breast Cancer Patients Undergoing Helical Tomotherapy Compared to Standard Radiation Therapy
A terminated clinical trial evaluated novel surrogate genetic markers to predict radiation toxicity in breast cancer patients treated with h…
-
CLINICAL_TRIALS withdrawal · 2016-02-24Clinical Trial Update: Frequency of Portal Images Required to Enhance Quality Assurance for Breast Cancer Patients Treated With Radiotherapy
Withdrawal notice for a trial evaluating how frequently portal imaging should be used to enhance quality assurance for breast cancer radioth…
-
CLINICAL_TRIALS trial_result · 2016-02-23Clinical Trial Update: Immunotherapy Combined With Capecitabine Versus Capecitabine Monotherapy in Advanced Breast Cancer [Phase 2]
A Phase 2 trial compares immunotherapy plus capecitabine versus capecitabine alone in advanced breast cancer. The study is currently active …
-
CLINICAL_TRIALS withdrawal · 2016-02-23Clinical Trial Update: The Use of Metformin in Early Breast Cancer Patients Pre-Surgery [EARLY_Phase 1]
A Phase 1 study investigating metformin in patients with early breast cancer prior to surgery has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2016-02-22Clinical Trial Update: Green Tea and Reduction of Breast Cancer Risk [Phase 2]
Phase 2 clinical trial assessing whether green tea consumption reduces breast cancer risk; the study is completed and results were posted in…
-
CLINICAL_TRIALS trial_result · 2016-02-22Clinical Trial Update: Automated Tele Counseling for Screening Mammography [Phase 1]
This clinical trial update reports a Phase 1 trial of automated tele-counseling to support screening mammography for breast cancer; the stud…
-
CLINICAL_TRIALS research · 2016-02-22Clinical Trial Update: An Observational Study of Avastin (Bevacizumab) in Patients With Metastatic Breast Cancer
Observational study results for Avastin (bevacizumab) in metastatic breast cancer have been posted after study completion.